Inicio › Cáncer metastásico › California › San Francisco
Ensayos clínicos de Cáncer metastásico en San Francisco, CA
28 estudios para Cáncer metastásico buscan participantes en centros de San Francisco y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, San Francisco
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
ReclutandoFase 1/2
- University of California San Francisco, San Francisco
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- UCSF at China Basin, San Francisco
- UCSF at Mount Zion, San Francisco
- UCSF at Parnassus, San Francisco
- y 1 más
Intratumoral N17350 in Advanced Solid Tumors
ReclutandoFase 1/2
- University of California, San Francisco, San Francisco
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ReclutandoFase 1
- UCSF Medical Center at Mount Zion, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutandoFase 3
- UCSF Medical Center at Mission Bay, San Francisco
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Kaiser Permanente, San Francisco
- UCSF Medical Center at Mission Bay, San Francisco
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
ReclutandoFase 1/2
- UCSF Medical Center at Mission Bay ( Site 0034), San Francisco
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
ReclutandoFase 1/2
- University of California, San Francisco (UCSF), San Francisco
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
ReclutandoFase 1
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
ReclutandoFase 1/2
- Crinetics Study Site, San Francisco
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
ReclutandoFase 2
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
ReclutandoFase 1
- University of California, San Francisco, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ReclutandoFase 1
- University of California San Francisco, San Francisco
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Exelixis Clinical Site #5, San Francisco
Combination Therapy in Cancers With Mutations in DNA Repair Genes
ReclutandoFase 1
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using FAP-2286
ReclutandoFase 1
- University of California, San Francisco, San Francisco
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
ReclutandoFase 1
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
ReclutandoFase 1/2
- University of California San Francisco (UCSF), San Francisco
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
ReclutandoFase 2/3
- University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco
Comparison of Whole Body DWI to FDG PET
Reclutando
- University of California, San Francisco, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
ReclutandoFase 1/2
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Venetoclax Basket Trial for High Risk Hematologic Malignancies
ReclutandoFase 1
- University of California San Francisco-Benioff Children's Hospital, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- University of California, San Francisco, San Francisco
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en San Francisco
- Cáncer de próstata45 estudios
- Cáncer de seno43 estudios
- Cáncer de pulmón de células no pequeñas36 estudios
- Cáncer (todos los tipos)35 estudios
- Fallo cardíaco29 estudios
- Cáncer de pulmón22 estudios
- Melanoma22 estudios
- Cáncer de páncreas20 estudios
- Cáncer de ovario19 estudios
- Cáncer del colon y del recto18 estudios
- Enfermedad cardiovascular18 estudios
- Glioblastoma17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.